Article
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Blood cancer journal - 1 Aug 2018
Bohers Elodie, Viailly Pierre-Julien, Becker Stéphanie, Marchand Vinciane, Ruminy Philippe, Maingonnat Catherine, Bertrand Philippe, Etancelin Pascaline, Picquenot Jean-Michel, Camus Vincent, Menard Anne-Lise, Lemasle Emilie, Contentin Nathalie, Leprêtre Stéphane, Lenain Pascal, Stamatoullas Aspasia, Lanic Hélène, Libraire Julie, Vaudaux Sandrine, Pepin Louis-Ferdinand, Vera Pierre, Tilly Hervé, Jardin Fabrice
Abstract excerpt
From a liquid biopsy, cell-free DNA (cfDNA) can provide information regarding basal tumoral genetic patterns and changes upon treatment. In a prospective cohort of 30 diffuse large B-cell lymphomas (DLBCL), we determined the clinical relevance of cfDNA using targeted next-generation sequencing and its correlation with PET scan imaging at the time of diagnosis and during treatment. Using a dedicated DLBCL panel,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
